文献速递中医内科中药与中成药合理使用

半夏-夏枯草药对改善睡眠剥夺的机制研究

Mechanism of action of the Banxia-Xiakucao herb pair in sleep deprivation: New comprehensive evidence from network pharmacology, transcriptomics and molecular biology experiments.
PubMed 文献 · J Ethnopharmacol · 2024-07-08

本研究采用网络药理学、分子对接、转录组学与分子生物学实验,探讨半夏-夏枯草药对(BXHP)改善睡眠剥夺(SD)的作用机制。大鼠实验显示BXHP可缩短睡眠潜伏期、延长睡眠时间、改善焦虑,并降低血清CORT、IL6、TNF-α、MDA及下丘脑Glu水平,升高下丘脑GABA和5-HT水平。机制上BXHP通过激活cAMP-PKA-CREB-昼夜节律通路,改善生物钟节律性。

要点

  • BXHP可缩短SD大鼠睡眠潜伏期、延长睡眠时间并改善焦虑。
  • BXHP降低血清CORT、IL6、TNF-α、MDA及下丘脑Glu,升高GABA和5-HT。
  • BXHP激活cAMP-PKA-CREB-昼夜节律通路,改善生物钟节律性。

核心结论

  • BXHP中的活性化合物可激活cAMP-PKA-CREB-昼夜节律通路,改善生物钟节律性,促进睡眠并改善焦虑。
  • BXHP通过多成分、多靶点、多途径机制改善睡眠剥夺。

研究设计与样本

  • 采用UPLC-Q-TOF-MS表征BXHP成分,结合ADME数据筛选活性化合物。
  • 运用网络药理学与分子对接预测BXHP改善SD的分子机制。
  • 建立大鼠SD模型,通过戊巴比妥钠翻正反射试验、行为学实验、ELISA、透射电镜、HE染色和尼氏染色验证体内药效。
  • 通过转录组学与生物信息学分析,结合qRT-PCR、Western blot和免疫荧光染色揭示分子机制。

主要发现

  • BXHP降低SD大鼠睡眠潜伏期、延长睡眠时间并改善焦虑。
  • BXHP降低血清CORT、IL6、TNF-α和MDA水平,降低下丘脑Glu水平,升高下丘脑GABA和5-HT水平。
  • 发现16种活性化合物作用于583个靶点,其中145个与SD相关。
  • PPI网络模块分析发现Akt1、CREB1和PRKACA三个关键靶点。
  • 分子对接显示16种活性化合物与关键靶点强结合。

临床怎么用

  • 半夏-夏枯草药对可能通过调节cAMP-PKA-CREB-昼夜节律通路改善睡眠剥夺及相关焦虑。
  • 临床可考虑将BXHP用于睡眠剥夺伴焦虑状态的患者,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Chinese herb pairs are the most basic and compressed examples of Chinese herbal combinations and can be used to effectively explain the fundamental concepts of traditional Chinese medicine prescriptions. These pairings have gained significant interest due to their subtle therapeutic benefits, minimal side effects, and efficacy in treating complicated chronic conditions. The Banxia-Xiakucao Chinese herb pair (BXHP) consists of Pinellia ternata (Thunb.) Breit. (Banxia) and Prunella vulgaris L. (Xiakucao). This formula was documented in The Medical Classic of the Yellow Emperor approximately 2000 years ago,and clinical research has demonstrated that BXHP effectively treats insomnia. AIM OF THE STUDY: This study aimed to evaluate the efficacy and therapeutic mechanism of the BXHP through a comprehensive strategy involving network pharmacology, molecular docking, transcriptomics, and molecular biology experimental validation. MATERIALS AND METHODS: The composition of BXHP was characterized using the UPLC-Q-TOF-MS. The active compounds were screened to find drug-likeness compounds by analyzing the ADME data. To predict the molecular mechanism of BXHP in sleep deprivation (SD) by network pharmacology and molecular docking. We established a rat model of SD and the in vivo efficacy of BXHP was verified through the pentobarbital sodium righting reflex test, behavioral assays, enzyme-linked immunosorbent assay, transmission electron microscopy, HE staining, and Nissl staining, and the underlying molecular mechanism of BXHP in SD was revealed through transcriptomic and bioinformatic analyses in conjunction with quantitative real-time PCR, Western blot, and immunofluorescence staining. RESULTS: In the present study, we showed for the first time that BXHP reduced sleep latency, prolongs sleep duration, and improves anxiety; lowered serum CORT, IL6, TNF-α and MDA levels; decreased hypothalamic Glu levels; and elevated hypothalamic GABA and 5-HT levels in SD rats. We found 16 active compounds that acted on 583 targets, 145 of which are related to SD. By modularly dissecting the PPI network, we discovered three critical targets, Akt1, CREB1, and PRKACA, all of which play important roles in the effects of BXHP on SD. Molecular docking resulted in the identification of 16 active compounds that strongly bind to key targets. The results of GO and KEGG enrichment analyses of network pharmacology and transcriptomics focused on both the regulation of circadian rhythm and the cAMP signaling pathway, which strongly demonstrated that BXHP affects SD via the cAMP-PKA-CREB-Circadian rhythm pathway. Molecular biology experiments verified this hypothesis. Following BXHP administration, PKA and CREB phosphorylation levels were elevated in SD rats, the cAMP-PKA-CREB signaling pathway was activated, the expression levels of the biological clock genes CLOCK, p-BMAL1/BMAL1, and PER3 were increased, and the rhythmicity of the biological clock was improved. CONCLUSIONS: The active compounds in BXHP can activate the cAMP-PKA-CREB-Circadian rhythm pathway, improve the rhythmicity of the biological clock, promote sleep and ameliorate anxiety, which suggests that BXHP improves SD through a multicomponent, multitarget, multipathway mechanism. This study is important for the development of herbal medicines and clinical therapies for improving sleep deprivation.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang ZY, You LY, Liu YF, et al. Mechanism of action of the Banxia-Xiakucao herb pair in sleep deprivation: New comprehensive evidence from network pharmacology, transcriptomics and molecular biology experiments. J Ethnopharmacol. 2024. PMID: 38986753. doi:10.1016/j.jep.2024.118534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。